Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

Journal of Neuroimmunology

Volumn 133, Issue 1-2, 2002, Pages 124-131

  Yuan, Michael ^a   Kiertscher, Sylvia M ^a   Cheng, Qingwen ^a   Zoumalan, Richard ^a   Tashkin, Donald P ^a   Roth, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presentation; Cytokines; Flow cytometry; Human; T helper 1; T helper 2

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; LIGAND; MESSENGER RNA; T HELPER 1 ASSOCIATED CYTOKINE; T HELPER 2 ASSOCIATED CUTOKINE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INTERFERON PRODUCTION; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CANNABINOIDS; CELL DIVISION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MARIJUANA ABUSE; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; TETRAHYDROCANNABINOL; TH1 CELLS; TH2 CELLS;

EID: 0036889699     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00370-3     Document Type: Article

References (40)

1. Baldwin G.C., Tashkin D.P., Buckley D.M., Park A.N., Dubinett S.M., Roth M.D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156:1997;1606-1613.
2. Baran J., Kowalczyk D., Ozog M., Zembala M. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin. Diagn. Lab. Immunol. 8:2001;303-313.
3. Berdyshev E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids. 108:2000;169-190.
4. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
5. Caiaffa W.T., Vlahov D., Graham N.M., Astemborski J., Solomon L., Nelson K.E., Munoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am. J. Respir. Crit. Care Med. 150:1994;1493-1498.
6. Derocq J.M., Segui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369:1995;177-182.
7. Elenkov I.J., Webster E.L., Torpy D.J., Chrousos G.P. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann. N.Y. Acad. Sci. 876:1999;1-11.
8. - lymphocyte subpopulation. J. Immunol. 154:1995;4294-4301.
9. Faubert B.L., Kaminski N.E. AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun. J. Leukoc. Biol. 67:2000;259-266.
10. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
11. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
12. Kaminski N.E. Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. J. Neuroimmunol. 83:1998;124-132.
13. Kaminski N.E., Koh W.S., Yang K.H., Lee M., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48:1994;1899-1908.
14. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukoc. Biol. 59:1996;208-218.
15. Klein T.W., Newton C., Friedman H. Cannabinoid receptors and immunity. Immunol. Today. 19:1998;373-381.
16. 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta2 responses to Legionella pneumophila infection. J. Immunol. 164:2000;6461-6466.
17. 9-tetrahydrocannabinol. Science. 192:1976;805-807.
18. Lee M., Yang K.H., Kaminski N.E. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275:1995;529-536.
19. Manzanares J., Corchero J., Fuentes J.A. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res. 839:1999;173-179.
20. Marchand J., Bord A., Penarier G., Laure F., Carayon P., Casellas P. Quantitative method to determine mRNA levels by reverse transcriptase-polymerase chain reaction from leukocyte subsets purified by fluorescence-activated cell sorting: application to peripheral cannabinoid receptors. Cytometry. 35:1999;227-234.
21. Massi P., Fuzio D., Vigano D., Sacerdote P., Parolaro D. Relative involvement of cannabinoid CB(1) and CB(2) receptors in the delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity. Eur. J. Pharmacol. 387:2000;343-347.
22. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
23. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
24. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
25. 9-tetrahydrocannabinol (THC) in rodents. Nature. 243:1973;407-408.
26. Nahas G.G., Suciu-Foca N., Armand J.-P., Morishima A. Inhibition of cellular mediated immunity in marihuana smokers. Science. 183:1974;419-420.
27. Newell G.R., Mansell P.W., Wilson M.B., Lynch H.K., Spitz M.R., Hersh E.M. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev. Med. 14:1985;81-91.
28. 9-tetrahydrocannabinol injection. Infect. Immun. 62:1994;4015-4020.
29. Nong L., Newton C., Cheng Q., Friedman H., Roth M.D., Klein T.W. Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J. Neuroimmunol. 127:2002;169-176.
30. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 81:1998;275-283.
31. Ouyang Y., Hwang S.G., Han S.H., Kaminski N.E. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53:1998;676-683.
32. Paria B.C., Ma W., Andrenyak D.M., Schmid P.C., Schmid H.H., Moody D.E., Deng H., Makriyannis A., Dey S.K. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol. Reprod. 58:1998;1490-1495.
33. Rachelefsky G.S., Opelz G., Mickey M.R., Lessin P., Kiuchi M., Silverstein M.J., Stiehm E.R. Intact humoral and cell-mediated immunity in chronic marijuana smoking. J. Allergy Clin. Immunol. 58:1976;483-490.
34. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Brelière J.C., Le Fur G. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
35. Roth M.D. Interleukin-2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes. J. Exp. Med. 179:1994;857-864.
36. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., Kaminski N.E. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142:1997;278-287.
37. Schylze-Koops H., Lipsky P.E., Davis L.S. Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligation. Eur. J. Immunol. 28:1998;2517-2529.
38. Smith S.R., Terminelli C., Denhardt G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther. 293:2000;136-150.
39. Tindall B., Cooper D.A., Donovan B., Barnes T., Philpot C.R., Gold J., Penny R. The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust. N.Z. J. Med. 18:1988;8-15.
40. 9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165:2000;373-380.